CXCL9 and neoplasm: Further elaborating on the role of CXCR3 ligand chemokines, such as CXCL9 and CXCL10, Vonderhaar et al. reported that utilizing a stimulator of interferon genes (STINGs) agonist promoted effector T-cell infiltration and anti-tumor effects in a CXCR3-dependent manner [125].